CYTOKINETICS INC — Director's Dealing 2021

Nov 5, 2021

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: CYTOKINETICS INC (CYTK)
CIK: 0001061983
Period of Report: 2021-11-05

Reporting Person: PARSHALL B LYNNE (Director)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2021-11-05	Common Stock	M	20000	$14.25	Acquired	25000	Direct
2021-11-05	Common Stock	S	20000	$40.0	Disposed	5000	Direct
2021-11-05	Common Stock	M	4032	$12.4	Acquired	9032	Direct
2021-11-05	Common Stock	S	4032	$40.0	Disposed	5000	Direct
2021-11-05	Common Stock	M	4166	$6.78	Acquired	9166	Direct
2021-11-05	Common Stock	S	4166	$40.0	Disposed	5000	Direct
2021-11-05	Common Stock	M	2798	$6.84	Acquired	7798	Direct
2021-11-05	Common Stock	S	2798	$40.0	Disposed	5000	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2021-11-05	Non-Qualified Stock Option (right to buy)	$6.78	M	4166	Disposed	2023-05-22	Common Stock (4166)	Direct
2021-11-05	Non-Qualified Stock Option (right to buy)	$6.84	M	2798	Disposed	2023-04-01	Common Stock (2798)	Direct
2021-11-05	Non-Qualified Stock Option (right to buy)	$12.4	M	4032	Disposed	2027-01-03	Common Stock (4032)	Direct
2021-11-05	Non-Qualified Stock Option (right to buy)	$14.25	M	20000	Disposed	2027-05-18	Common Stock (20000)	Direct

Footnotes

F1: Transaction effected pursuant to a 10b5-1 plan meeting the requirements of Rule 10b5-1(c) under the Exchange Act entered into by the Reporting Person on August 17, 2021.